Literature DB >> 19434928

Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy.

Maeve K Lalor1, Anne Ben-Smith, Patricia Gorak-Stolinska, Rosemary E Weir, Sian Floyd, Rose Blitz, Hazzie Mvula, Melanie J Newport, Keith Branson, Nuala McGrath, Amelia C Crampin, Paul E M Fine, Hazel M Dockrell.   

Abstract

Bacille Calmette-Guérin (BCG) vaccination induces a marked increase in the interferon (IFN)-gamma response to Mycobacterium tuberculosis purified protein derivative (Mtb PPD) in UK adolescents, but not in Malawian adolescents. We hypothesized that Mtb PPD-induced IFN-gamma after BCG vaccination would be similar in infants from these 2 countries. Infants were vaccinated with BCG during the first 3-13 weeks of life. Three months after BCG vaccination, 51 (100%) of 51 UK infants had an IFN-gamma response to Mtb PPD, compared to 41 (53%) of 78 of Malawian infants, in whom responses varied according to their season of birth. We conclude that population differences in immune responses after BCG vaccination are observed among infants, as well as among young adults.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19434928      PMCID： PMC3276835          DOI： 10.1086/597069

Source DB:  PubMed          Journal:  J Infect Dis        ISSN： 0022-1899            Impact factor:   5.226


  13 in total

1.  Patterns and implications of naturally acquired immune responses to environmental and tuberculous mycobacterial antigens in northern Malawi.

Authors:  G F Black; H M Dockrell; A C Crampin; S Floyd; R E Weir; L Bliss; L Sichali; L Mwaungulu; H Kanyongoloka; B Ngwira; D K Warndorff; P E Fine
Journal:  J Infect Dis       Date:  2001-07-10       Impact factor: 5.226

2.  Bacillus Calmette Guerin vaccination of human newborns induces a specific, functional CD8+ T cell response.

Authors:  Rose Ann Murray; Nazma Mansoor; Ryhor Harbacheuski; Jorge Soler; Virginia Davids; Andreia Soares; Anthony Hawkridge; Gregory D Hussey; Holden Maecker; Gilla Kaplan; Willem A Hanekom
Journal:  J Immunol       Date:  2006-10-15       Impact factor: 5.422

3.  Neonatal bacillus Calmette-Guérin vaccination induces adult-like IFN-gamma production by CD4+ T lymphocytes.

Authors:  J Vekemans; A Amedei; M O Ota; M M D'Elios; T Goetghebuer; J Ismaili; M J Newport; G Del Prete; M Goldman; K P McAdam; A Marchant
Journal:  Eur J Immunol       Date:  2001-05       Impact factor: 5.532

Review 4.  Variation in protection by BCG: implications of and for heterologous immunity.

Authors:  P E Fine
Journal:  Lancet       Date:  1995-11-18       Impact factor: 79.321

5.  Protective effect of BCG against tuberculous meningitis and miliary tuberculosis: a meta-analysis.

Authors:  L C Rodrigues; V K Diwan; J G Wheeler
Journal:  Int J Epidemiol       Date:  1993-12       Impact factor: 7.196

6.  The influence of previous exposure to environmental mycobacteria on the interferon-gamma response to bacille Calmette-Guérin vaccination in southern England and northern Malawi.

Authors:  R E Weir; G F Black; B Nazareth; S Floyd; S Stenson; C Stanley; K Branson; L Sichali; S D Chaguluka; L Donovan; A C Crampin; P E M Fine; H M Dockrell
Journal:  Clin Exp Immunol       Date:  2006-12       Impact factor: 4.330

7.  Effect of month of vaccine administration on antibody responses in The Gambia and Pakistan.

Authors:  Sophie E Moore; Andrew C Collinson; Anthony J C Fulford; Fehmida Jalil; Claire-Anne Siegrist; David Goldblatt; Lars A Hanson; Andrew M Prentice
Journal:  Trop Med Int Health       Date:  2006-10       Impact factor: 2.622

8.  BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies.

Authors:  Gillian F Black; Rosemary E Weir; Sian Floyd; Lyn Bliss; David K Warndorff; Amelia C Crampin; Bagrey Ngwira; Lifted Sichali; Bernadette Nazareth; Jenefer M Blackwell; Keith Branson; Steven D Chaguluka; Linda Donovan; Elizabeth Jarman; Elizabeth King; Paul E M Fine; Hazel M Dockrell
Journal:  Lancet       Date:  2002-04-20       Impact factor: 79.321

9.  Effects of antenatal and postnatal environments on CD4 T-cell responses to Mycobacterium bovis BCG in healthy infants in the Gambia.

Authors:  David J C Miles; Marianne van der Sande; Sarah Crozier; Olubukola Ojuola; Melba S Palmero; Mariama Sanneh; Ebrima S Touray; Sarah Rowland-Jones; Hilton Whittle; Martin Ota; Arnaud Marchant
Journal:  Clin Vaccine Immunol       Date:  2008-04-09

10.  Interferon-gamma and skin test responses of schoolchildren in southeast England to purified protein derivatives from Mycobacterium tuberculosis and other species of mycobacteria.

Authors:  R E Weir; P E M Fine; B Nazareth; S Floyd; G F Black; E King; C Stanley; L Bliss; K Branson; H M Dockrell
Journal:  Clin Exp Immunol       Date:  2003-11       Impact factor: 4.330
View more
  59 in total

Review 1.  Recent Trends in System-Scale Integrative Approaches for Discovering Protective Antigens Against Mycobacterial Pathogens.

Authors:  Aarti Rana; Shweta Thakur; Girish Kumar; Yusuf Akhter
Journal:  Front Genet       Date:  2018-11-27       Impact factor: 4.599

Review 2.  Tuberculosis vaccines in clinical trials.

Authors:  Rosalind Rowland; Helen McShane
Journal:  Expert Rev Vaccines       Date:  2011-05       Impact factor: 5.217

Review 3.  Factors That Influence the Immune Response to Vaccination.

Authors:  Petra Zimmermann; Nigel Curtis
Journal:  Clin Microbiol Rev       Date:  2019-03-13       Impact factor: 26.132

4.  Longitudinal changes in CD4(+) T-cell memory responses induced by BCG vaccination of newborns.

Authors:  Andreia P Soares; Cheong K C Kwong Chung; Terry Choice; E Jane Hughes; Gail Jacobs; Esme Janse van Rensburg; Gloria Khomba; Marwou de Kock; Lesedi Lerumo; Lebohang Makhethe; Mbulelo H Maneli; Bernadette Pienaar; Erica Smit; Nontobeko G Tena-Coki; Leandre van Wyk; W Henry Boom; Gilla Kaplan; Thomas J Scriba; Willem A Hanekom
Journal:  J Infect Dis       Date:  2013-01-04       Impact factor: 5.226

5.  Identification of immunological biomarkers which may differentiate latent tuberculosis from exposure to environmental nontuberculous mycobacteria in children.

Authors:  Yun-Gyoung Hur; Amelia C Crampin; Christina Chisambo; James Kanyika; Rein Houben; Richard Ndhlovu; Themba Mzembe; Maeve K Lalor; Jacky Saul; Keith Branson; Carolynne Stanley; Bagrey Ngwira; Neil French; Tom H Ottenhoff; Hazel M Dockrell; Patricia Gorak-Stolinska
Journal:  Clin Vaccine Immunol       Date:  2013-11-27

6.  Oral polio vaccine influences the immune response to BCG vaccination. A natural experiment.

Authors:  Erliyani Sartono; Ida M Lisse; Elisabeth M Terveer; Paula J M van de Sande; Hilton Whittle; Ane B Fisker; Adam Roth; Peter Aaby; Maria Yazdanbakhsh; Christine S Benn
Journal:  PLoS One       Date:  2010-05-21       Impact factor: 3.240

7.  A longitudinal study of BCG vaccination in early childhood: the development of innate and adaptive immune responses.

Authors:  Yenny Djuardi; Erliyani Sartono; Heri Wibowo; Taniawati Supali; Maria Yazdanbakhsh
Journal:  PLoS One       Date:  2010-11-19       Impact factor: 3.240

8.  Strain-specific differences in the genetic control of two closely related mycobacteria.

Authors:  Tania Di Pietrantonio; Carmen Hernandez; Manon Girard; Annie Verville; Marianna Orlova; Adam Belley; Marcel A Behr; J Concepción Loredo-Osti; Erwin Schurr
Journal:  PLoS Pathog       Date:  2010-10-28       Impact factor: 6.823

9.  Delaying BCG vaccination from birth to 10 weeks of age may result in an enhanced memory CD4 T cell response.

Authors:  Benjamin M N Kagina; Brian Abel; Mark Bowmaker; Thomas J Scriba; Sebastian Gelderbloem; Erica Smit; Mzwandile Erasmus; Nonhlanhla Nene; Gerhard Walzl; Gillian Black; Gregory D Hussey; Anneke C Hesseling; Willem A Hanekom
Journal:  Vaccine       Date:  2009-07-17       Impact factor: 3.641

10.  Complex cytokine profiles induced by BCG vaccination in UK infants.

Authors:  Maeve K Lalor; Steven G Smith; Sian Floyd; Patricia Gorak-Stolinska; Rosemary E Weir; Rose Blitz; Keith Branson; Paul E Fine; Hazel M Dockrell
Journal:  Vaccine       Date:  2009-11-24       Impact factor: 3.641
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.